ST Pharm Co.Ltd Cash Flow Conversion Efficiency
ST Pharm Co.Ltd cash flow conversion efficiency. Based on the latest financial reports, ST Pharm Co.Ltd (237690) has a cash flow conversion efficiency ratio of -0.036x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-21.16 Billion ≈ $-14.34 Million USD) by net assets (₩593.00 Billion ≈ $401.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of ST Pharm Co.Ltd (2015–2025)
Cash flow conversion efficiency of ST Pharm Co.Ltd from 2015 to 2025. This chart illustrates how ST Pharm Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 237690 stock price and chart for real-time trading data and today's change.
ST Pharm Co.Ltd Cash Flow Conversion Ratio Explained
ST Pharm Co.Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
ST Pharm Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ST Pharm Co.Ltd ranked by their cash flow conversion efficiency. Also see ST Pharm Co.Ltd market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hefei Urban Construction Development Co Ltd
SHE:002208
|
-0.260x |
|
Whirlpool China Co Ltd
SHG:600983
|
0.057x |
|
Energi Mega Persada Tbk
JK:ENRG
|
0.094x |
|
Bata India Limited
NSE:BATAINDIA
|
0.166x |
|
Hubei Jiuzhiyang Infrared System Co Ltd
SHE:300516
|
0.011x |
|
Aarti Pharmalabs Limited
NSE:AARTIPHARM
|
0.019x |
|
Hangzhou Cogeneration Group Co Ltd
SHG:605011
|
0.006x |
|
Jiangsu Shentong Valve Co Ltd
SHE:002438
|
0.027x |
Annual Cash Flow Conversion Efficiency for ST Pharm Co.Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of ST Pharm Co.Ltd from 2015 to 2025. Review ST Pharm Co.Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩593.00 Billion ≈ $401.87 Million |
₩13.99 Billion ≈ $9.48 Million |
0.024x | -89.16% |
| 2024-12-31 | ₩502.99 Billion ≈ $340.87 Million |
₩109.45 Billion ≈ $74.17 Million |
0.218x | +6384.31% |
| 2023-12-31 | ₩386.91 Billion ≈ $262.20 Million |
₩1.30 Billion ≈ $879.90K |
0.003x | -83.89% |
| 2022-12-31 | ₩337.63 Billion ≈ $228.81 Million |
₩7.03 Billion ≈ $4.76 Million |
0.021x | -7.48% |
| 2021-12-31 | ₩322.97 Billion ≈ $218.87 Million |
₩7.27 Billion ≈ $4.93 Million |
0.023x | +131.75% |
| 2020-12-31 | ₩295.33 Billion ≈ $200.14 Million |
₩-20.93 Billion ≈ $-14.19 Million |
-0.071x | +30.09% |
| 2019-12-31 | ₩300.96 Billion ≈ $203.95 Million |
₩-30.52 Billion ≈ $-20.68 Million |
-0.101x | -412.25% |
| 2018-12-31 | ₩331.57 Billion ≈ $224.70 Million |
₩10.77 Billion ≈ $7.30 Million |
0.032x | -79.06% |
| 2017-12-31 | ₩351.08 Billion ≈ $237.92 Million |
₩54.44 Billion ≈ $36.89 Million |
0.155x | -4.35% |
| 2016-12-31 | ₩313.24 Billion ≈ $212.28 Million |
₩50.78 Billion ≈ $34.41 Million |
0.162x | -42.38% |
| 2015-12-31 | ₩127.33 Billion ≈ $86.29 Million |
₩35.82 Billion ≈ $24.28 Million |
0.281x | -- |
About ST Pharm Co.Ltd
ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea. The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; analytical characterization; and CMC documentation. It… Read more